Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

NCT07697456 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Crohn's Disease
Ulcerative Colitis

Interventions

DRUG: Risankizumab
DRUG: Trosunilimab
DRUG: ABBV-701

Sponsor

AbbVie